Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein–Based Vaccine Adjuvanted With Glucopyranosyl Lipid A–Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge is a research paper published in The Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0.344. It has been cited 7 times, with 5 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0.0323
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 5 citers.
NIAID NIH HHS
Grant: K23 AI125720
NIAID NIH HHS
Grant: T32 AI007524
NIAID NIH HHS
Grant: K23 AI155838
Passano Foundation
T32 Fellowship Training Program in Vaccinology
NIAID Malaria Vaccine Production Support Services
American Society of Tropical Medicine and Hygiene
NIH HHS
National Institute of Allergy and Infectious Diseases
National Institutes of Health
National Institute of Allergy and Infectious Diseases
NIH HHS
T32 Fellowship Training Program in Vaccinology
American Society of Tropical Medicine and Hygiene
Passano Foundation
NIAID Malaria Vaccine Production Support Services
FWCI
2.93
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals